A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Trial details
- Registry ID
- NCT05712356
- Drugs studied
- Cisplatin, Durvalumab, FOLFOX regimen, Gemcitabine and 1 more
TrialRedline tracks 3 clinical trials sponsored by Lisata Therapeutics, Inc.: 3 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsNCT05712356 | Cisplatin, Durvalumab, FOLFOX regimen, Gemcitabine and 1 more | Completed | 2026-04-05Actual |
| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)NCT02501018 | CLBS12, SOC | Completed | 2022-05-19Actual |
| A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular DysfunctionNCT04614467 | CLBS16 | Terminated | 2022-09-28Actual |
Names as written in the registry records.
NCT05712356 · Lisata Therapeutics, Inc.
Before: Terminated. After: Completed.
NCT05712356 · Lisata Therapeutics, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of adverse events. After: Measure: Number of Subjects Experiencing Any Adverse Event.
Before: 67 participants (actual). After: 66 participants (actual).
Before: Estimated. After: Actual.
Before: 18 Apr 2026. After: 5 Apr 2026.
Before: Active not recruiting. After: Terminated.
NCT04614467 · Lisata Therapeutics, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Change From Baseline in Angina Frequency Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL). After: Measure: Change From Baseline in Number of Angina Attacks Per Week Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL).